Autolus Therapeutics plc (AUTL) Stock Message Board

Post	Subject
#14	ASH abstracts	jondoeuk	11/04/20 07:01:27 PM
#13	ESMO webcast https://services.choruscall.com/links/autl200918.html	jondoeuk	09/18/20 05:08:11 PM
#12	AUTO3 is a first-in-class anti-CD19/22 CAR-T with novel	jondoeuk	06/01/20 01:15:21 PM
#11	AACR II: AUTO6NG https://www.abstractsonline.com/pp8/#!/9045/presentation/7894	jondoeuk	05/15/20 09:18:03 PM
#10	EHA: AUTO1 https://library.ehaweb.org/eha/2020/eha25th/294939/claire.roddie.allcar19.updated.data.us	jondoeuk	05/15/20 09:15:04 PM
#9	The FDA has accepted the IND application for	jondoeuk	04/22/20 09:10:20 PM
#8	Vector supply https://pipelinereview.com/index.php/2020030973972/More-News/MolMe	jondoeuk	03/13/20 06:40:13 PM
#7	J.P. Morgan webcast https://jpmorgan.metameetings.net/events/hc20/sessions/29708	jondoeuk	01/26/20 03:11:05 PM
#6	Here is a link to the ASH investor	jondoeuk	12/09/19 04:05:56 PM
#5	Here is the link to the ASH Data	jondoeuk	12/08/19 01:34:37 PM
#4	The company has inked an agreement with Noile-Immune	jondoeuk	11/16/19 12:59:49 PM
#3	The AUTO6NG product consists of three distinct populations	jondoeuk	11/16/19 12:57:15 PM
#2	A new(ish) paper https://www.nature.com/articles/s41591-019-0549-5	jondoeuk	10/24/19 04:49:00 PM
#1	SITC (P146) AUTO6NG: Next generation GD2-targeting CAR T-cell	jondoeuk	10/01/19 06:27:35 PM
Post	Subject

AUTL News: Autolus Therapeutics to host Investor Conference Call to discuss AUTO1 and AUTO3 data presented at ASH and to participate in ...	11/17/2020 07:00:00 AM
AUTL News: Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	11/05/2020 04:04:54 PM
AUTL News: Autolus Therapeutics Reports Third Quarter 2020 Financial Results and Operational Progress	11/05/2020 07:00:00 AM
AUTL News: Autolus Therapeutics to Report Third Quarter 2020 Financial Results and Host Conference Call on November 5	10/30/2020 07:00:10 AM
AUTL News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	09/18/2020 08:01:56 AM

Autolus Therapeutics plc (AUTL)